Epigenetic targeting of MECOM/KRAS axis by JIB-04 impairs tumorigenesis and cisplatin resistance in MECOM-amplified ovarian cancer - Cell Death Discovery Cell Death Discovery - Epigenetic targeting of MECOM/KRAS axis by JIB-04 impairs tumorigenesis and cisplatin resistance in MECOM-amplified ovarian cancer

Happy to share two big milestones—PhD completed & our main study now published in Cell Death Discovery www.nature.com/articles/s41...
Currently seeking postdoc roles!

#Postdoc #Epigenetics #PhDComplete #PostdocCancer #PostdocEpigenetics #Cancer #CisplatinResistance

Big congrats to Dr. Qiuci Luo from Ralph Bock’s group at the @mpi-mp-potsdam.bsky.social for successfully defending her thesis “Exploring plastid-nucleus interactions in the genus Nicotiana through horizontal transfer of plastids”! Time to celebrate—no citations required. 🍾 #PhDComplete

Exciting News! I've successfully passed my PhD viva. Grateful to examiners Adam Rutland and Amanda Fitzgerald for their insightful discussion. Special thanks to my supervisor, Laura Taylor, for her unwavering support. Appreciate everyone who supported me on this journey. #PhDComplete #Gratitude

Celebrating a major milestone: I've successfully defended my PhD and am now officially a doctor!
I am very grateful for the years of growth and achievement.

I am also thrilled to officially announce that I will now be joining the Kelly lab and @eDNAcollab as a postdoc at UW🎉🔬 #PhDComplete